Metropolitan Life Insurance CO Relay Therapeutics, Inc. Transaction History

Metropolitan Life Insurance CO

$2.27 Billion
Q1 2024

A detailed history of Metropolitan Life Insurance CO transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Metropolitan Life Insurance CO holds 5,222 shares of RLAY stock, worth $33,211. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,222

Previous 5,222 -0.0%

Holding current value

$33,211

Previous $57,000 24.56%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$8.24 - $12.97 $3,164 - $4,980	384 Added 7.94%	5,222 $43,000
Q1 2023 May 15, 2023	SELL	$15.0 - $22.76 $6,390 - $9,695	-426 Reduced 8.09%	4,838 $79,000
Q4 2022 Jun 14, 2023	BUY	$14.16 - $24.02 $6,032 - $10,232	426 Added 8.81%	5,264 $78.6 Million
Q4 2022 Mar 30, 2023	BUY	$14.16 - $24.02 $9,996 - $16,958	706 Added 15.49%	5,264 $78,000
Q4 2022 Feb 15, 2023	BUY	$14.16 - $24.02 $9,996 - $16,958	706 Added 15.49%	5,264 $78,000

Q3 2022 Jun 14, 2023	SELL	$18.07 - $31.37 $5,059 - $8,783	-280 Reduced 5.79%	4,558 $102 Million
Q2 2022 Jun 20, 2023	SELL	$13.31 - $34.88 $3,726 - $9,766	-280 Reduced 5.79%	4,558 $76,000
Q1 2022 Jun 20, 2023	SELL	$20.26 - $32.36 $5,672 - $9,060	-280 Reduced 5.79%	4,558 $136,000
Q1 2022 Mar 30, 2023	SELL	$20.26 - $32.36 $274,239 - $438,024	-13,536 Reduced 74.81%	4,558 $136,000
Q1 2022 May 12, 2022	SELL	$20.26 - $32.36 $274,239 - $438,024	-13,536 Reduced 74.81%	4,558 $136,000
Q4 2021 Jun 21, 2023	BUY	$26.0 - $37.03 $344,656 - $490,869	13,256 Added 274.0%	18,094 $555,000
Q4 2021 Mar 30, 2023	BUY	$26.0 - $37.03 $47,060 - $67,024	1,810 Added 11.12%	18,094 $555,000
Q4 2021 Feb 15, 2022	BUY	$26.0 - $37.03 $47,060 - $67,024	1,810 Added 11.12%	18,094 $556,000
Q3 2021 Jun 21, 2023	BUY	$29.75 - $37.99 $340,518 - $434,833	11,446 Added 236.59%	16,284 $513,000
Q2 2021 Jun 21, 2023	BUY	$27.5 - $38.19 $314,765 - $437,122	11,446 Added 236.59%	16,284 $595,000
Q2 2021 Mar 30, 2023	BUY	$27.5 - $38.19 $94,957 - $131,870	3,453 Added 26.91%	16,284 $595,000
Q2 2021 Aug 16, 2021	BUY	$27.5 - $38.19 $447,452 - $621,389	16,271 Added 125161.54%	16,284 $596,000
Q1 2021 Jun 26, 2023	BUY	$32.52 - $61.53 $259,932 - $491,809	7,993 Added 165.21%	12,831 $444 Million
Q1 2021 Mar 30, 2023	BUY	$32.52 - $61.53 $110,763 - $209,571	3,406 Added 36.14%	12,831 $443,000
Q1 2021 May 14, 2021	SELL	$32.52 - $61.53 $306,078 - $579,120	-9,412 Reduced 99.86%	13 $444,000
Q4 2020 Jun 22, 2023	BUY	$35.51 - $54.03 $162,884 - $247,835	4,587 Added 94.81%	9,425 $391,000
Q3 2020 Jun 26, 2023	BUY	$32.81 - $45.1 $150,499 - $206,873	4,587 Added 94.81%	9,425 $401,000
Q3 2020 Mar 30, 2023	BUY	$32.81 - $45.1 $136,522 - $187,661	4,161 Added 79.05%	9,425 $401,000
Q3 2020 Nov 13, 2020	BUY	$32.81 - $45.1 $309,234 - $425,067	9,425 New	9,425 $401,000

Others Institutions Holding RLAY

# of Institutions

188

Shares Held

127M

Call Options Held

4.2K

Put Options Held

1.7K

View Full List

About Relay Therapeutics, Inc.

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $765M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

More about RLAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account

Metropolitan Life Insurance CO Relay Therapeutics, Inc. Transaction History